How PAD Testing Helps Independent Practices Detect Vascular Disease Early

Peripheral arterial disease (PAD) affects approximately 8.5 million Americans, yet up to 75% of cases remain undiagnosed until complications become severe. For independent medical practices, adding in-office PAD testing represents both a clinical imperative and a significant practice growth opportunity.

What Is PAD and Why Does Early Detection Matter?

PAD occurs when plaque buildup narrows the arteries that carry blood to the legs, feet, and other extremities. Left undetected, PAD significantly increases the risk of heart attack, stroke, and limb amputation. The challenge is that many patients with PAD experience no symptoms in the early stages, or they attribute leg pain and fatigue to aging rather than vascular disease.

Early detection through non-invasive testing allows physicians to intervene before the disease progresses to critical limb ischemia. This is where in-office diagnostic devices become essential for independent practices that want to deliver comprehensive vascular care without referring patients out.

How Does In-Office PAD Testing Work?

Modern PAD testing uses the Ankle-Brachial Index (ABI) as its foundation — a comparison of blood pressure measured at the ankle versus the arm. An ABI below 0.9 indicates the presence of peripheral arterial disease. Advanced diagnostic systems like the CMAT Advantage go beyond basic ABI by also measuring Toe-Brachial Index (TBI), segmental blood volume plethysmography (SBV), heart rate variability (HRV), and sudomotor function in a single 7-to-10-minute test.

This comprehensive vascular and autonomic assessment gives physicians a detailed picture of cardiovascular risk, diabetic neuropathy indicators, and peripheral circulation — all from one non-invasive, FDA-cleared device operated by existing clinical staff.

Which Patients Should Be Screened for PAD?

The American Heart Association and the U.S. Preventive Services Task Force recommend PAD screening for patients who meet specific risk criteria. Independent practices should prioritize testing for:

• Patients aged 65 and older, regardless of risk factors
• Patients aged 50–64 with diabetes or a history of smoking
• Patients with known atherosclerotic disease in other vascular beds
• Patients reporting leg pain, cramping, or fatigue during walking (intermittent claudication)
• Diabetic patients, who face a 2–4x higher risk of PAD compared to the general population

By integrating routine PAD screening into annual wellness visits and chronic disease management protocols, independent practices can identify at-risk patients who might otherwise go undiagnosed until an emergency event.

What Are the Reimbursement Opportunities for PAD Testing?

One of the most compelling aspects of in-office PAD testing for independent practices is the reimbursement structure. Medicare and most commercial payers cover non-invasive vascular diagnostic testing when medical necessity criteria are met. A comprehensive vascular assessment can generate approximately $400 per test in reimbursement, creating a meaningful ancillary revenue stream while delivering better patient outcomes.

HealthWright Technologies provides full implementation support including credentialing guidance, billing training, and ongoing reimbursement optimization to help practices maximize their return on investment from day one. Our CMAT Advantage program includes the diagnostic device, staff training, clinical protocols, and dedicated support — everything an independent practice needs to launch a vascular screening program.

How Does PAD Testing Strengthen an Independent Practice?

Beyond the direct clinical and financial benefits, adding PAD testing positions an independent practice as a comprehensive cardiovascular care provider. This differentiation matters in competitive markets where patients and referring physicians look for practices that offer advanced diagnostics without the wait times and costs associated with hospital-based testing.

In-office PAD testing also supports value-based care models by enabling proactive disease management, reducing downstream emergency utilization, and improving quality metrics that affect practice reimbursement rates under Medicare’s Merit-based Incentive Payment System (MIPS).

Getting Started with PAD Testing in Your Practice

HealthWright Technologies, based in Watkinsville, Georgia, has been helping independent physicians integrate advanced diagnostic technology into their practices since 2000. Our team handles device setup, staff training, clinical protocol development, and ongoing support so that practices can begin testing patients within weeks of implementation.

Contact HealthWright Technologies at (678) 322-7146 to learn how PAD testing can improve patient outcomes and grow your practice.

This article is intended for healthcare professionals considering vascular diagnostic capabilities for their practice. It does not constitute medical advice for patients. Clinical decisions should be based on individual patient evaluation and current practice guidelines.